MYLOTARG 4.5 MG Injection
- RxCUI
- 1944704
- RxNorm name
- MYLOTARG 4.5 MG Injection
- Display name
- MYLOTARG 4.5 MG Injection
- Full name
- MYLOTARG 4.5 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761060 | Mylotarg | gemtuzumab ozogamicin | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mylotarg | GEMTUZUMAB OZOGAMICIN | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 32fd2bb2-1cfa-4250-feb8-d7956c794e05 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 1944704 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 32fd2bb2-1cfa-4250-feb8-d7956c794e05 | MYLOTARG 4.5 MG Injection [PSN] · gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg] [SBD] · Mylotarg 4.5 MG Injection [SY] | 3 | 19 | These highlights do not include all the information needed to use MYLOTARG safely and effectively. See full prescribing information for MYLOTARG. MYLOTARG™ (gemtuzumab ozogamicin) for injection, for intravenous use Initial U.S. Approval: 2000 | 20251219 |